Sol-Gel Technologies (SLGL) Prepaid Assets (2016 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Prepaid Assets of $1.9 million for Q1 2026, down 28.45% year-over-year from $2.6 million in Q1 2025, and up 88.65% quarter-over-quarter from $1.0 million in Q4 2025.
Analysis
Sol-Gel Technologies (SLGL) Prepaid Assets (2016 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Prepaid Assets for 11 consecutive years, with $1.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 28.45% year-over-year to $1.9 million; the TTM figure through Mar 2026 stood at $1.9 million (down 28.45% YoY), while the FY2025 annual figure was $1.0 million, down 73.4% from the prior year.
- Prepaid Assets rose to $1.9 million in Q1 2026 per SLGL's latest filing, from $1.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.8 million in Q4 2024 and bottomed at $747000.0 in Q1 2022.
- Historically, Prepaid Assets has averaged $1.9 million across 5 years, with a median of $1.9 million in 2026.
- Annual changes were most pronounced in 2022 — Prepaid Assets surged 88.62% — and 2025, when it tumbled 73.4%.
- Sol-Gel Technologies' Prepaid Assets stood at $1.5 million in 2022, then jumped by 85.16% to $2.8 million in 2023, then jumped by 35.08% to $3.8 million in 2024, then sank by 73.4% to $1.0 million in 2025, then soared by 88.65% to $1.9 million in 2026.
- Business Quant data shows SLGL's Prepaid Assets at $1.9 million in Q1 2026, $1.0 million in Q4 2025, and $962000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Sol-Gel Technologies | 194.01 Mn | 146.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.44 Mn |
| Mar 31, 2026 | 1.89 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 962,000.00 |
| Jun 30, 2025 | 1.94 Mn |
| Mar 31, 2025 | 2.65 Mn |
| Dec 31, 2024 | 3.77 Mn |
| Sep 30, 2024 | 2.88 Mn |
| Jun 30, 2024 | 1.75 Mn |
| Mar 31, 2024 | 2.12 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 2.41 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.69 Mn |
| Mar 31, 2022 | 747,000.00 |
| Dec 31, 2021 | 800,000.00 |
| Sep 30, 2021 | 1.17 Mn |